The cost and challenge of vaccine development for emerging and emergent infectious diseases
Lancet Glob Health
.
2018 Dec;6(12):e1266-e1267.
doi: 10.1016/S2214-109X(18)30418-2.
Epub 2018 Oct 18.
Author
Joel N Maslow
1
Affiliation
1
GeneOne Life Science Inc, Seoul, South Korea; Department of Medicine, Morristown Medical Center, Morristown, NJ, USA. Electronic address: jmaslow@geneonels-us.com.
PMID:
30342926
PMCID:
PMC7129672
DOI:
10.1016/S2214-109X(18)30418-2
No abstract available
Publication types
Comment
MeSH terms
Communicable Diseases*
Coronavirus Infections / prevention & control*
Epidemics*
Humans
Vaccines / immunology*
Substances
Vaccines